This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Wednesday, September 11, 2013
Investment Commentary; Sofosbuvir- Gilead's Lurking Hepatitis C Megablockbuster Drug
Investment Commentary
In this video, health care analysts David Williamson and Max Macaluso drill down on Gilead's strong drug development pipeline.
No comments:
Post a Comment